Highlights: Keto diets improve CAR T cell function in cancer models Beta-hydroxybutyrate (BHB) is the key metabo
Vous n'êtes pas connecté
Beta-hydroxybutyrate (BHB), a ketogenic diet metabolite, enhances CAR T cell activation, offering a cost-effective boost for cancer immunotherapy.
Highlights: Keto diets improve CAR T cell function in cancer models Beta-hydroxybutyrate (BHB) is the key metabo
Highlights: Keto diets improve CAR T cell function in cancer models Beta-hydroxybutyrate (BHB) is the key metabo
A ketogenic diet supplement could improve CAR T cell function, offering a potential boost to cancer therapy, according to new research.
MONDAY, Dec. 9, 2024 (HealthDay News) -- A component of the keto diet appears to boost the powers of immunotherapy in treating cancer, a new study...
A basic dietary supplement in a ketogenic diet can enhance the function of 'CAR T' cells - a personalized treatment that reprograms patients' immune...
Scientists have developed CCI-38, a compound that targets YTHDF2 to improve CAR T cell therapy and overcome immune evasion in cancer.
T-Mobile is accepting sign-ups for a beta offering of its direct-to-cell satellite service with Starlink . The beta service, set to begin testing next...
Researchers at Mount Sinai are developing a revolutionary pill using harmine, a DYRK1A inhibitor, to regenerate insulin-producing beta cells in the...
A preclinical study led by a faculty member at Roswell Park Comprehensive Cancer Center shows that gilteritinib, a targeted cancer treatment, can...
Ketogenic supplement shows promise as a new approach in cancer treatment, potentially aiding in tumor reduction and improving patient outcomes